ReviewNature reviews. Endocrinology2009
Nonfunctioning pituitary adenomas: the Oxford experience.
Review in Nature reviews. Endocrinology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- A Rare Association of Pituitary Macroadenoma With Nasopharyngeal Angiofibroma: A Case Report.Cureus · 2023Article
- Clinical Biology of the Pituitary Adenoma.Endocrine reviews · 2022Review
- Phosphorylation of β-catenin at Serine552 correlates with invasion and recurrence of non-functioning pituitary neuroendocrine tumours.Acta neuropathologica communications · 2022Article
- Screening and Identification of Key Microenvironment-Related Genes in Non-functioning Pituitary Adenoma.Frontiers in genetics · 2021Article
- Mortality in patients with non-functioning pituitary adenoma.Pituitary · 2018Review
- Role of prolactin/adenoma maximum diameter and prolactin/adenoma volume in the differential diagnosis of prolactinomas and other types of pituitary adenomas.Oncology letters · 2018Article
- Vanishing Pituitary Macroadenoma: A Case Report.Cureus · 2016Article
- Pituitary Medicine From Discovery to Patient-Focused Outcomes.The Journal of clinical endocrinology and metabolism · 2016Review
- The prevalence of hyperprolactinemia in non-functioning pituitary macroadenomas.International journal of clinical and experimental medicine · 2015Article
- Whole-exome sequencing studies of nonfunctioning pituitary adenomas.The Journal of clinical endocrinology and metabolism · 2013Article
- Treatment with octreotide LAR in clinically non-functioning pituitary adenoma: results from a case-control study.Pituitary · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nonfunctioning adenomas are the second most common type of pituitary tumor. Over the past few years, our knowledge of the epidemiology, natural history, diagnosis, treatment, and recurrence rates of these tumors has improved. Here, we highlight some of these advances and speculate on future avenues of research. In addition, we describe our own experience in the clinical management of patients with nonfunctioning adenomas. Serum prolactin levels are generally <2,000 mU/l in patients with these tumors; we propose that this level be used as the cut-off to differentiate nonfunctioning from prolactin-secreting adenomas. Despite increases in size in 19% of the microadenomas we studied, none of the patients who received no intervention developed visual complications. By contrast, 50% of untreated macroadenomas enlarged and 67% of affected patients experienced worsened or new visual-field defects. Although most recurrences develop in the first 5 years, recurrence has been reported up 14 years after surgery.
Indexed as
Identifiers
19690562What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.